Ultralife Stock Today

ULBI Stock  USD 7.16  0.28  3.76%   

Performance

Very Weak

 
Weak
 
Strong

Odds Of Distress

Very Low

 
High
 
Low
Ultralife is trading at 7.16 as of the 17th of February 2025. This is a 3.76% down since the beginning of the trading day. The stock's open price was 7.44. Ultralife has a very small chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 28th of February 2023 and ending today, the 17th of February 2025. Click here to learn more.
Business Domain
Capital Goods
IPO Date
23rd of December 1992
Category
Industrials
Ultralife Corporation, together with its subsidiaries, designs, manufactures, installs, and maintains power, and communication and electronics systems worldwide. The company was incorporated in 1990 and is headquartered in Newark, New York. Ultralife Corp operates under Electrical Equipment Parts classification in the United States and is traded on NASDAQ Exchange. The company has 16.62 M outstanding shares of which 205.24 K shares are at this time shorted by private and institutional investors with about 2.95 trading days to cover. More on Ultralife
Follow Valuation Options Odds of Bankruptcy
Check how we calculate scores

Ultralife Stock Highlights

ESG Sustainability
Environmental
Governance
Social
CEO PresidentMichael Manna
Business ConcentrationElectrical Components & Equipment, Electrical Equipment & Parts, Industrials, NASDAQ Composite, NASDAQ Composite Total, Industrials, Electrical Equipment, Electrical Equipment & Parts, Industrials (View all Sectors)
Average Analyst Recommendation
Financial Strength
Current ValueLast YearChange From Last Year 10 Year Trend
Asset Turnover0.640.8
Significantly Down
Pretty Stable
Total Current Liabilities17.5 M27.3 M
Way Down
Slightly volatile
Non Current Liabilities Total35.2 M33.5 M
Sufficiently Up
Slightly volatile
Total Assets215.3 M205 M
Sufficiently Up
Slightly volatile
Total Current Assets54.7 M103.7 M
Way Down
Slightly volatile
Debt Levels
Ultralife can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Ultralife's financial leverage. It provides some insight into what part of Ultralife's total assets is financed by creditors.
Liquidity
Ultralife currently holds 29.16 M in liabilities with Debt to Equity (D/E) ratio of 0.2, which may suggest the company is not taking enough advantage from borrowing. Ultralife has a current ratio of 3.18, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Ultralife's use of debt, we should always consider it together with its cash and equity.

Change In Working Capital

(9.44 Million)
Ultralife (ULBI) is traded on NASDAQ Exchange in USA. It is located in 2000 Technology Parkway, Newark, NY, United States, 14513 and employs 536 people. Ultralife is listed under Electrical Components & Equipment category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 132.82 M. Ultralife conducts business under Electrical Equipment sector and is part of Industrials industry. The entity has 16.62 M outstanding shares of which 205.24 K shares are at this time shorted by private and institutional investors with about 2.95 trading days to cover. Ultralife currently holds about 5.11 M in cash with 1.93 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.32.
Check Ultralife Probability Of Bankruptcy
Ownership Allocation
Ultralife shows a total of 16.62 Million outstanding shares. The majority of Ultralife outstanding shares are owned by institutional holders. These institutional investors are usually referred to as non-private investors looking to take positions in Ultralife to benefit from reduced commissions. Consequently, institutions are subject to a different set of regulations than regular investors in Ultralife. Please pay attention to any change in the institutional holdings of Ultralife as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Ultralife Ownership Details

Ultralife Stock Institutional Holders

InstituionRecorded OnShares
Jpmorgan Chase & Co2024-09-30
94.9 K
Citadel Advisors Llc2024-09-30
91.7 K
Northern Trust Corp2024-09-30
81.1 K
Bridgeway Capital Management, Llc2024-09-30
81.1 K
Clarivest Asset Management Llc2024-09-30
66.7 K
Trexquant Investment Lp2024-09-30
50.8 K
Bank Of New York Mellon Corp2024-12-31
43.5 K
Morgan Stanley - Brokerage Accounts2024-09-30
34.8 K
Ubs Group Ag2024-09-30
34.6 K
Visionary Wealth Advisors2024-09-30
1.1 M
Dimensional Fund Advisors, Inc.2024-12-31
1.1 M
View Ultralife Diagnostics

Ultralife Historical Income Statement

As of now, Ultralife's EBIT is increasing as compared to previous years. The Ultralife's current EBITDA is estimated to increase to about 18.2 M, while Depreciation And Amortization is projected to decrease to under 2.9 M. View More Fundamentals

Ultralife Stock Against Markets

Ultralife Corporate Executives

Elected by the shareholders, the Ultralife's board of directors comprises two types of representatives: Ultralife inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Ultralife. The board's role is to monitor Ultralife's management team and ensure that shareholders' interests are well served. Ultralife's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Ultralife's outside directors are responsible for providing unbiased perspectives on the board's policies.
Philip FainCFO, Principal Accounting Officer, Treasurer and SecretaryProfile
Philip CPATreasurer CFOProfile
When determining whether Ultralife offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Ultralife's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Ultralife Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Ultralife Stock:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Ultralife. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.
For more detail on how to invest in Ultralife Stock please use our How to Invest in Ultralife guide.
You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Is Electrical Components & Equipment space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ultralife. If investors know Ultralife will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ultralife listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.81)
Earnings Share
0.58
Revenue Per Share
10.02
Quarterly Revenue Growth
(0.1)
Return On Assets
0.0435
The market value of Ultralife is measured differently than its book value, which is the value of Ultralife that is recorded on the company's balance sheet. Investors also form their own opinion of Ultralife's value that differs from its market value or its book value, called intrinsic value, which is Ultralife's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ultralife's market value can be influenced by many factors that don't directly affect Ultralife's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ultralife's value and its price as these two are different measures arrived at by different means. Investors typically determine if Ultralife is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ultralife's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.